Loading…

Cardiovascular, Pulmonary, and Renal Scope

Element Considered Final Measures in Toolkit
N-terminal-pro-brain natriuretic peptide (NT-proBNP) N-terminal-pro-brain natriuretic peptide (NT-proBNP)
Cardiovascular Complications
Right Heart Catheterization (RHC) Right Heart Catheterization (RHC)
Iron overload Serum or Plasma Ferritin
Hemolytic Component Reticulocyte Count
Haptoglobin Level
Bilirubin Level
Lactate Dehydrogenase Level
Red Blood Cell Aspartate Aminotransferase Level
Brachial Artery Relaxivity
Short Axis Function
Pulmonary Complications
Asthma/airways disease Lung Function - Diffusion Capacity
Lung Function - Lung Volume
Acute chest syndrome Chest X-ray
Sleep Disordered Breathing
Other Complications
Temperature Body Temperature
Liver iron

Neurology, Quality of Life, and Health Services Scope

Element Considered Final Measures in Toolkit
Neurologic Complications
Silent Stroke Stroke Impact/Outcome
Overt Stroke Functionality after Stroke
Transcranial Doppler (TCD) Stroke Risk in Children with Sickle Cell Disease
Diffusion Tensor Imaging (DTI)
Angiography
Non-stroke neurologic complications
Cognitive complications
  • Dementia, Visual Memory, Working Memory, Executive Function, Attention
Adaptive Behavior/Adaptive Function
Intelligence Scale
Transfusion
Acute and Chronic Pain
Interference
Use of Substances of Addiction
  • Marijuana use
Transfusion
Quality of Life and Patient-Reported Outcomes
Functional measures of well-being
  • Fatigue, pain, pain interference, depression, anxiety, mobility
Quality of Life in Sickle Cell Disease
Self-efficacy in Sickle Cell Disease
Pain
  • Treatment, symptoms, communication, worry (pediatric)
Activities of Daily Living
  • Physical, social, emotional, school functioning
Health Services
Quality of Care - Hospitalization, re-hospitalization - TCD, treatments, medications Quality of Care
Preventive care (flu shots, hydroxyurea)
Acute Care
Quality indicators for pediatric sickle cell disease

Curative Therapies Scope

Element Considered Final Measures in Toolkit
Indications for Transplant
Pretransplant Evalution Prothrombin Time
Left Ventricular Global Longitudinal Strain by Speckle Tracking Echocardiography
Determination of Liver Iron Concentration by R2*
Determination of Liver Iron Concentration by Ferriscan
Determination of Liver Fibrosis by Magnetic Resonance Elastography (MRE) (Supplemental Information)
Recurrent Priapism
Psychosocial Assessment of Candidates for Transplantation
Fibrosis Staging of Liver Biopsy (Supplemental Information)
Determination of Liver Fibrosis by Transient Elastography (Supplemental Information)
Myocardia Iron Estimation Using T2* MRI (Supplemental Information)
Description of transplant conditioning regimen Sickle Cell Disease Transplant Conditioning Regimen
Transplant stem cell source Sickle Cell Disease Stem Cell Source and Cell Manipulation
Effect of transplant on donor derived erythropoiesis
Endpoints for curative therapy (complications) White Cell Chimerism and Graft Failure
Graft versus Host Disease
Pretransfusion evaluation
Endpoints for Transfusion Pre-transfusion Antibody Testing
Transfusion Reaction Reporting
Thyroid Stimulating Hormone (hTSH) in Serum
Endpoints for transplant (complications) Determination of Liver Iron Concentration by R2*
Determination of Liver Iron Concentration by Ferriscan
Determination of Liver Fibrosis by Magnetic Resonance Elastography (MRE) (Supplemental Information)
Fibrosis Staging of Liver Biopsy (Supplemental Information)
Determination of Liver Fibrosis by Transient Elastography (Supplemental Information)
Myocardia Iron Estimation Using T2* MRI (Supplemental Information)

Pain Scope

Element Considered Final Measures in Toolkit
Intensity Pain Intensity
Location Pain Location
Pain Quality Pain Quality Descriptors
Anxiety: Pain-related, state, trait, disorder
Catastrophizing Pain Catastrophizing
Coping Pain Coping
Emotional
Psychosocial
Self-efficacy
Social
Care utilization
Frequency
Pain Burden Pain Burden
Physical Interference/Impact Pain Interference
Physical Mobility
Medication use Treatment Response: Medication Use
Patient reported treatment, satisfaction, or effectiveness Patient Reported Impression of Change

Psychosocial and Social Determinants of Health Scope

Element Considered Final Measures in Toolkit
Transition Readiness Sickle Cell Disease Transition Readiness Assessment
Sickle Cell Disease Transition Readiness Assessment (SI)
Response to Stress Sickle Cell Disease Responses to Stress - Youth
Sickle Cell Disease Responses to Stress - Parent Report
Self-Management Sickle Cell Disease Self-Management - Adolescent Skills Checklist
Sickle Cell Disease Self-Management - Caregiver Skills Checklist
Stigma Sickle Cell Disease Health-Related Stigma - Child
Sickle Cell Disease Health-Related External Stigma - Adolescent and Adult
Sickle Cell Disease Health-Related Internal Stigma - Adolescent and Adult
Trust in Medical Care and Research Trust in the Medical Professional - Adult
Trust in Medical Researchers - 12-item
Trust in Medical Researchers - 4-item
Grief Inventory of Complicated Grief
Reactions to Loss Scale
Resilience Resilience
Spiritual Coping Religious Behaviors and Congregational Support
Attitude Toward Illness Attitude Toward Illness - Child (SI)
Self-Efficacy General Self-Efficacy - Child (SI)
General Self-Efficacy - Adolescent (SI)
General Self-Efficacy - Child Parent Report (SI)
General Self-Efficacy - Adult (SI)
Illness Identity Illness Identity Questionnaire (SI)
Medication Adherence Medication Adherence (SI)
Optimism Optimism (SI)
Self-Perception Self-Perception Profile - Child (SI)
Self-Perception Profile - Adolescent (SI)
Self-Perception Profile - Adult (SI)

Genitourinary Scope

Element Considered Final Measures in Toolkit
Puberty
Menstruation Sickle Cell Disease Pain Associated with Menstruation
Sickle Cell Disease Pain Associated with Menstruation - Quality of Life
Contraception Female Contraception Use
Priapism Priapism
Fertility Fertility and Quality of Life
Fertility History
Infertility
Testosterone Deficiency Testosterone Level
Sexual Function Sexual Function
Sexual, Romantic, and Partner Satisfaction
Exogenous hormone use Hormone Therapy
Menopause Perimenopausal Symptoms
Voiding Dysfunction Overactive Bladder